Cholecystokinin-B Receptor-Targeted Nanoparticle for Imaging and Detection of Precancerous Lesions in the Pancreas
Survival from pancreatic cancer remains extremely poor, in part because this malignancy is not diagnosed in the early stages, and precancerous pancreatic intraepithelial neoplasia (PanIN) lesions are not seen on routine radiographic imaging. Since the cholecystokinin-B receptor (CCK-BR) becomes over...
Main Authors: | Jill P. Smith, Hong Cao, Elijah F. Edmondson, Siva Sai Krishna Dasa, Stephan T. Stern |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/12/1766 |
Similar Items
-
The Expression of Two Distinct Sets of Glycolytic Enzymes Reveals Differential Effects of Glycolytic Reprogramming on Pancreatic Ductal Tumorigenesis in Mice
by: Yannan Zhang, et al.
Published: (2023-11-01) -
Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions
by: Geou-Yarh Liou, et al.
Published: (2016-03-01) -
Zebrafish model of KRAS-initiated pancreatic cancer
by: Joon Tae Park, et al.
Published: (2018-11-01) -
Does Neoplastic Cholecystokinin Expression Reflect the Embryonal Pattern of the Protein? A Study in Human Pancreas
by: Demetrio Tamiolakis, et al.
Published: (2004-01-01) -
Preneoplastic Lesions in Surgical Specimens Do Not Worsen the Prognosis of Patients Who Underwent Surgery for Pancreatic Adenocarcinoma: Post-Hoc Analysis of the PRODIGE 24-CCTG PA 6 Trial
by: Théo Legrand, et al.
Published: (2022-08-01)